GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Global Cord Blood Corp (OTCPK:CORBF) » Definitions » Cyclically Adjusted Revenue per Share

Global Cord Blood (Global Cord Blood) Cyclically Adjusted Revenue per Share : $0.00 (As of Mar. 2022)


View and export this data going back to 2007. Start your Free Trial

What is Global Cord Blood Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Global Cord Blood's adjusted revenue per share for the three months ended in Mar. 2022 was $0.386. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Mar. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-05-14), Global Cord Blood's current stock price is $1.25. Global Cord Blood's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2022 was $0.00. Global Cord Blood's Cyclically Adjusted PS Ratio of today is .


Global Cord Blood Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Global Cord Blood's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Cord Blood Cyclically Adjusted Revenue per Share Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Global Cord Blood's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Global Cord Blood's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Cord Blood's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Global Cord Blood's Cyclically Adjusted PS Ratio falls into.



Global Cord Blood Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Global Cord Blood's adjusted Revenue per Share data for the three months ended in Mar. 2022 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2022 (Change)*Current CPI (Mar. 2022)
=0.386/113.5581*113.5581
=0.386

Current CPI (Mar. 2022) = 113.5581.

Global Cord Blood Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201206 0.239 89.373 0.304
201209 0.284 87.834 0.367
201212 0.299 91.132 0.373
201303 0.377 92.122 0.465
201306 0.255 93.001 0.311
201309 0.317 91.902 0.392
201312 0.294 95.090 0.351
201403 0.503 95.749 0.597
201406 0.306 96.409 0.360
201409 0.339 97.948 0.393
201412 0.331 99.707 0.377
201503 0.502 99.927 0.570
201506 0.374 99.267 0.428
201509 0.369 99.927 0.419
201512 0.328 102.015 0.365
201603 0.401 102.785 0.443
201606 0.367 101.686 0.410
201609 0.378 102.565 0.419
201612 0.364 103.225 0.400
201703 0.490 103.335 0.538
201706 0.295 103.664 0.323
201709 0.315 103.994 0.344
201712 0.324 104.984 0.350
201803 0.266 105.973 0.285
201806 0.300 106.193 0.321
201809 0.296 106.852 0.315
201812 0.307 107.622 0.324
201903 0.303 108.172 0.318
201906 0.326 109.601 0.338
201909 0.363 110.260 0.374
201912 0.392 110.700 0.402
202003 0.353 110.920 0.361
202006 0.326 110.590 0.335
202009 0.345 107.512 0.364
202012 0.366 109.711 0.379
202103 0.382 111.579 0.389
202106 0.403 111.360 0.411
202109 0.398 109.051 0.414
202112 0.412 112.349 0.416
202203 0.386 113.558 0.386

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Global Cord Blood  (OTCPK:CORBF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Global Cord Blood Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Global Cord Blood's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Cord Blood (Global Cord Blood) Business Description

Traded in Other Exchanges
N/A
Address
1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.
Executives
Kent C Mccarthy 10 percent owner, other: Mbr 13(d) grp own 10% plus 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Fund Ii Lp 10 percent owner 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
7-2010 Grat 5 Under Kent C. Mccarthy Grat Tr Dtd 4-23-2010 other: 13 (d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
7-2010 Grat 6 Under Kent C Mccarthy Grat Tr Dtd 4-23-2010 10 percent owner, other: Member of 13(d) group owning m 7335 COTTONWOOD, SHAWNEE KS 66216
Mccarthy Family Sd, Llc 10 percent owner, other: 13 (d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Fund Ii, Llc other: 13(d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Management Ii, Llc other: 13(d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jcf Co Lf, L.p. other: 13(d) group owning > 10% 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Capital Management Llc other: Member of the group 13021 W 74TH ST, SHAWNEE KS 66216
Jayhawk China Fund Cayman Ltd other: Member of the group 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Gp Ii, L.p. 10 percent owner 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
Jayhawk Private Equity, Llc 10 percent owner 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205